Considering the importance of lactate metabolism in tumor progression, we hypothesized that crizotinib could obstruct the CD147–MCT1 interaction and influence MCT1 localization on the cell membrane, thereby affecting lactate transport in melanoma cells. The gene discussed is SLC16A1; the disease is melanoma.